CureVac (NASDAQ:CVAC) Earns Market Outperform Rating from JMP Securities
CureVac (NASDAQ:CVAC – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by stock analysts at JMP Securities in a report issued on Wednesday,Benzinga reports. They currently have a $10.00 target price on the stock. JMP Securities’ price target suggests a potential upside of 115.98% from the stock’s current price. Separately, UBS Group reduced […]
